⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 17, 2024Frontiers in NeuroscienceOpen Access

Epigenetic alterations in creatine transporter deficiency: a new marker for dodecyl creatine ester therapeutic efficacy monitoring

Léa Broca-Brisson Clémence Disdier Rania Harati Rifat Hamoudi Aloı̈se Mabondzo

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Creatine transporter deficiency (CTD) is an X-linked disease caused by mutations in the

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Broca-Brisson et al. (2024) studied this question.

synapsesocial.com/papers/68e6ebd7b6db643587666c6a https://doi.org/10.3389/fnins.2024.1362497

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Dodecyl creatine ester therapy: from promise to reality2024 · 2 citations
2Modern approaches to the diagnosis and treatment of X-linked creatine transporter deficiency: literature review and own observation2025
3Advancing clinical insight into creatine transporter deficiency: long term outcome and new observations from the Italian cohortCohort Study · 2026
4Clinical Characteristics, Developmental Trajectory, and Caregiver Burden of Patients With Creatine Transporter Deficiency ( <i>SLC6A8</i> )2024 · 7 citations
5Clinical Characteristics of Creatine Transporter Deficiency (CTD): Final Results of the Vigilan Observational Study (P8-8.002)2024 · 1 citations